About this episode
Hablamos con Carlos Buesa, Director General d Oryzon, sobre los datos clínicos de su fármaco para la leucemia mieloide aguda
Comments
Rate this episode
Episode Details
- Author
- Rocío Arviza
- Show Type
- full
- Audio Format
- audio/mpeg
Hablamos con Carlos Buesa, Director General d Oryzon, sobre los datos clínicos de su fármaco para la leucemia mieloide aguda
We use analytics
We use Umami, a privacy-friendly analytics tool, to understand how visitors use this site. No personal data is collected and no data leaves our EU servers. You can accept or decline below. Privacy Policy